THE GOOD ECONOMY
With a business model based on high quality drugs, Aurora Biofarma is carving out an important market niche (10 million turnover forecast for 2015) in a sector dominated by multinationals. CEO Di Trapani "But the state doesn't help us hire"
by Alexis Paparo July 11, 2014 Economy up.it Italy that wants to grow
That the sector pharmaceutical in Italy is not in excellent health it has been known for at least two decades. At least thirteen closed or decommissioned research and production centers since 1998, especially of majors such as Pfizer, Novartis, Sanofi Aventis. Yet i numbers, which make Italy second only to Germany for the value of pharmaceutical production in Europe, are very respectable: 174 factories, 62,300 employees (90% graduates or graduates), 28 billion of production, of which 71 per cent is destined for the foreign market.